Taneli Jouhikainen
Directeur/Bestuurslid bij Mirror Biologics Inc
Oorsprong van het eerstegraads netwerk van Taneli Jouhikainen
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
19
| Public Company | Pharmaceuticals: Major | 19 |
Akela Pharma, Inc.
 Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX.
14
| Extinct | Pharmaceuticals: Major | 14 |
| Public Company | Pharmaceuticals: Major | 8 | |
Bayer Schering Pharma AG
7
| Extinct | Medical Specialties | 7 |
Mirror Biologics Inc
 Mirror Biologics Inc BiotechnologyHealth Technology Mirror Biologics Inc manufactures immune modulatory vaccines and therapeutics. The company is based in Tampa, FL. The company was founded in 2019 by Michael Har-Noy. Michael Har-Noy has been the CEO since 2019.
7
| Holding Company | Biotechnology | 7 |
AKELA Pharma Oy
 AKELA Pharma Oy Pharmaceuticals: OtherHealth Technology AKELA Pharma Oy, founded in 2000, develops inhalers, inhalation products, and related production technology. The company is based in Turku, Finland. AKELA Pharma was acquired by LAB International, Inc. on January 12, 2004 for $1.85 million.
2
| Extinct | Pharmaceuticals: Other | 2 |
LAB International, Inc.
 LAB International, Inc. Pharmaceuticals: MajorHealth Technology LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies
1
| Extinct | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Taneli Jouhikainen via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | President Chief Tech/Sci/R&D Officer | |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| LINEAGE CELL THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Investor Relations Contact | |
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Waratah Pharmaceuticals, Inc.
 Waratah Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Part of OPKO Health, Inc., Waratah Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in Calgary, Canada. The Canadian company was founded by Susan Dana Jones. Waratah Pharmaceuticals was acquired by Transition Therapeutics, Inc., part of OPKO Health, Inc. from September 01, 2016 on January 28, 2002 for $15.46 million. | Medical Specialties | Director of Finance/CFO | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
| McGill University | College/University | Masters Business Admin | |
| Texas A&M University | College/University | Undergraduate Degree | |
| The University of Texas at Austin | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| LUMOS PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BBS-BIOACTIVE BONE SUBSTITUTES OYJ | Medical Specialties | Director/Board Member Comptroller/Controller/Auditor | |
| New York University | College/University | Masters Business Admin Masters Business Admin | |
| Technical University of Berlin | College/University | Undergraduate Degree Doctorate Degree | |
| Erasmus University Rotterdam | College/University | Doctorate Degree Graduate Degree | |
Alethia Biotherapeutics, Inc.
 Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| ACERUS PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member | |
BioAxone Therapeutic, Inc.
 BioAxone Therapeutic, Inc. Medical/Nursing ServicesHealth Services BioAxone Therapeutic, Inc. provides an experimental therapy for the treatment of neurological disorders. The company was founded in April 2000 by Pierre Caouette and Lisa Mckerracher and is headquartered in Montreal, Canada. | Medical/Nursing Services | Chairman | |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| University of Quebec | College/University | Undergraduate Degree | |
| VALEO PHARMA INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| BANGI INC. | Biotechnology | Director/Board Member | |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Avistone Pharmaceuticals
 Avistone Pharmaceuticals BiotechnologyHealth Technology Avistone Pharmaceuticals is a Chinese clinical-stage biotechnology company that specializes in precision oncology therapeutics. The company is located in China. | Biotechnology | Director/Board Member | |
Tenacia Biotechnology (Shanghai) Co. Ltd.
 Tenacia Biotechnology (Shanghai) Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Tenacia Biotechnology (Shanghai) Co. Ltd. is a Chinese company that focuses on researching and developing innovative treatments for central nervous system disorders. | Miscellaneous Commercial Services | Director/Board Member | |
| CHITOGENX INC. | Biotechnology | Director of Finance/CFO | |
Zucara Therapeutics, Inc.
 Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Chairman | |
| University of Georgia | College/University | Undergraduate Degree | |
| University of San Diego School of Law | College/University | Graduate Degree | |
| Santa Clara University | College/University | Undergraduate Degree | |
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 23 |
| Canada | 16 |
| Duitsland | 3 |
| China | 3 |
| Finland | 2 |
Sectoraal
| Health Technology | 25 |
| Consumer Services | 14 |
| Commercial Services | 6 |
| Health Services | 2 |
| Producer Manufacturing | 2 |
Operationeel
| Director/Board Member | 232 |
| Corporate Officer/Principal | 121 |
| Independent Dir/Board Member | 56 |
| Chief Executive Officer | 52 |
| Director of Finance/CFO | 52 |
Sterkste connecties
| Insiders | |
|---|---|
| Joel Kanter | 52 |
| Peter Greenleaf | 31 |
| Claus Tycho Bræstrup | 27 |
| Yuri Pikover | 25 |
| Luc Mainville | 24 |
| Michael Kauffman | 24 |
| Ricky Sun | 24 |
| Gregory Schiffman | 22 |
| Joseph McCracken | 20 |
| Howard C. Dittrich | 17 |
| Robert W. Rieder | 16 |
| Klaus Kühn | 15 |
| Matthew Pauls | 14 |
| Brandi Roberts | 14 |
| David Ramsay | 13 |
- Beurs
- Insiders
- Taneli Jouhikainen
- Bedrijfsconnecties
